FDA chief expresses concern over potential leadership and policy changes under Trump's second term.

FDA Commissioner Robert Califf expressed uncertainty about changes under President-elect Trump's second term, hinting at potential shifts in leadership and policy. Trump has promised a significant role for vaccine skeptic Robert F Kennedy Jr in public health decisions, which could disrupt the agency. Califf hopes that knowledgeable staff will remain to ensure public health welfare.

November 13, 2024
7 Articles

Further Reading